Culture is an overlooked competitive advantage: lessons from top biotech execs
Creating a culture of transparency and accountability is important – not just for driving company outcomes, but also for motivating team
Plan smartly, execute precisely: the high-stakes game of chasing biotech value inflections
Successfully reaching the market in biotech hinges on building and maintaining a well-defined roadmap. One that clearly outlines the milestones
Not your average data room
Data rooms are central in biotech: not only do they underpin key events like fundraising, asset licensing, and M&
Why complex industries need special tools
Complex industries like biotech involve specialized people working in specialized ways. To power this effectively, underlying tools need to have
Drug discovery: what is it and why does data integrity matter?
Drug discovery is a complex journey that involves making crucial decisions at various stages, based on key data coming from
Before AI, there was good data
An often under-appreciated fact: when it comes to AI, not all data is equally amenable to applications of ML. In
A Kaleidoscope of People: Dr. Adam Mepham
Welcome back to another edition of 'A Kaleidoscope of People', a series of posts that showcases the incredible
Products vs services: biotech edition
Over the years at Kaleidoscope, we’ve noticed a quirk in biotech and pharma companies that often surprises people not
5 biotech observations to take into 2024
Happy 2024! Welcoming a new year is a wonderful opportunity to reflect on the past year of learnings and growth.
Your moat is your data, not your models
In biotech, your technical moat is key. But not all technical components are equally defensible. In this Kaleidoscope blog post,